Labial arteriovenous malformations (AVMs) pose a great challenge due to their location, angiogenic potential, and recurrence rate. Emerging treatments include sclerotherapy, such as intra-arterial bleomycin, which has been proven safe and effective in adults; however, there is limited literature available for children. Here, we present two successful cases of intra-arterial bleomycin use for treating lip AVMs in children, resulting in complete cure and no recurrence after a two-year follow-up period. Our findings support the limited but growing body of literature that presents intra-arterial bleomycin as a safe and viable option for pediatric facial AVMs.
LinhD-TNKhanhLDungLT, et al.Recurrence after treatment of arteriovenous malformations of the head and neck. AIMS Med Sci2022; 9: 9–17.
2.
RosenbergTSuenJRichterG. Arteriovenous malformations of the head and neck. Otolaryngol Clin North Am2018; 51: 185–195.
3.
LeeSYKangDHKimYS, et al.Efficacy and safety of transarterial bleomycin sclerotherapy of early-stage facial arteriovenous malformation: single-center multidisciplinary team experience. J Plast Reconstr Aesthet Surg2023; 77: 379–387.
4.
TanoueSTanakaNKoganemaruM, et al.Head and neck arteriovenous malformations: clinical manifestations and endovascular treatments. Interv Radiol (Higashimatsuyama)2023; 8: 23–35.
5.
LiljeDWiesmannMHasanD, et al.Interventional therapy of extracranial arteriovenous malformations of the head and neck – a systematic review. PLoS One2022; 17: e0268809.
6.
CollettiGTrotoloASannaG, et al.Surgical treatment of small-sized S3 arterio-venous malformations with neo-adjuvant and adjuvant bleomycin. J Craniomaxillofac Surg2024;52:1288–1292.
7.
JinYZouYHuaC, et al.Treatment of early-stage extracranial arteriovenous malformations with intralesional interstitial bleomycin injection: a pilot study. Radiology2018; 287: 194–204.
8.
LiXFanX-DWangD-M, et al.[Clinical analysis of interventional embolization for 9 cases with frontal arteriovenous malformation]. Shanghai Kou Qiang Yi Xue2023; 32: 332–336.
